The growing incidence and the wide diversity of carbapenemase-producing bacterial strains is a major concern as only a few antimicrobial agents are active on carbapenemresistant bacteria. This study was designed to study molecular epidemiology of carbapenem-resistant Gram-negative bacterial (GNB) isolates from the community and hospital settings.
worldwide because of their high prevalence, wide range of clinical infections, multidrug resistance and rapid dissemination of plasmid-mediated resistance genes from Enterobacteriaceae to other organisms. These enzymes confer resistance to the other β-lactam agents as well and are generally co-associated with resistance genes for aminoglycosides, quinolones and have brought us a step closer to the challenge of extremely drug-resistant bacteria 1, 2 . This study was designed to study molecular epidemiology of carbapenem-resistant bacterial isolates from community and hospital settings from north India and further explore therapeutic options for management of infections caused by carbapenem-resistant Gramnegative bacteria (GNB).
Material & Methods
The present study was conducted from August 2014 to July 2016 at the department of Microbiology, Ganesh Shankar Vidyarthi Memorial Medical College (GSVM), Kanpur, India. The clinical specimens were collected from primary Health Centre Kalyanpur, district hospital Kanpur and LLRM Hospital, a tertiary care centre attached with GSVM Medical College, Kanpur. The study was cleared by the Institutional Ethics Committee.
Non-duplicate GNB isolated from various specimens were identified using conventional techniques 3 . Antimicrobial susceptibility was performed by Kirby Bauer disk diffusion method 3 and minimum inhibitory concentration (MIC) breakpoints of carbapenems for the isolates which were resistant by disc diffusion testing was determined by E-test (BioMérieux, France). Further to look for treatment options for these carbapenem-resistant isolates MIC of other antibiotics such as fosfomycin, minocycline, chloramphenicol and tigecycline was also determined using E Strip and colistin MIC was determined using broth microdilution method, results were interpreted as per Clinical and Laboratory Standards Institute (CLSI) guidelines 4 .
The isolation of genomic DNA of carbapenemresistant bacteria was done by QuiAmp mini DNA extraction kit (Qualigens, Germany) and multiplex PCR was performed to identify the presence of following genes bla IMP , bla VIM , bla KPC , bla OXA48 , bla OXA23 , bla SPM , bla GIM , bla SIM and bla NDM using the primers and protocol described earlier 5 . New Delhi metallo-β-lactamase (NDM) positive amplicons were sequenced and previously published sequences of NDM isolates retrieved from the National Center for 6 were performed on carbapenem-resistant PCR-positive bacterial isolates.
Results & Discussion
A total of 8973 samples were processed and 3414 GNB were isolated; of which 312 (9.20%) isolates were carbapenem-resistant. Maximum resistance (11.2%) was present at tertiary care centre, followed by secondary care (4.0%) and primary centre (2.1%). Amongst the carbapenem-resistant bacteria; overall, the most common isolate was Pseudomones aeruginosa (24%) followed by Acinetobacter spp. (22%) and Escherichia coli (16%) ( Table I ). In a community-based study from south India Sekar et al , surveillance data were collected and compiled from four tertiary care centres in India, and a high meropenem resistance of 42, 47 and 62 per cent was reported among members of Enterobacteriaceae, P. aeruginosa and A. baumannii, respectively.
On multiplex PCR 282 of 312 (90.3%) isolates were positive f or carbapenemase gene. The bla NDM 178 (63%) was the most prevalent gene followed by bla VIM (18.4%). The bla KPC , bla GIM and bla SIM were not isolated in this study; bla NDM and bla OXA48 were co-observed in 20 per cent isolates (Table II) . Sequencing was performed on 178 bla NDM positive isolates and 133 (75%) isolates were carrying bla NDM-1 and the rest were harbouring bla NDM-5 genes. The findings were in concurrence to previously published reports from India 9, 10 . Some NDM-positive isolates were earlier screened for the coexistence of ESBL genes, 16s methyltransferase genes determining aminoglycosides resistance and quinolones resistance determinants and it was found that NDM positive isolates were co-harbouring several other resistance determinants 11 . In contrast to western literature 1 , bla KPC was not isolated in this study.
Phenotypic carbapenemase detection test was performed on 261 PCR confirmed isolates. Rapidec Carba NP test, Neo-Sensitabs and MHT and showed a sensitivity of 90, 73 and 20 per cent, respectively. MIC of the isolates resistant to carbapenem was determined Providencia sp. 12
Morganella morganii 9

Alcaligenes faecalis 8
Stenotrophomonas maltophilia 5
Unidentified 9 Total 3414 312 (9.20) 312
GNB, Gram-negative bacteria for other antibiotics such as chloramphenicol, colistin, fosfomycin, minocycline and tigecycline (Table III) .
Carbapenemases are generally encoded by a genetic element found on different plasmids that may jump from bacteria to bacteria easily causing the rapid emergence of multidrug-resistant bacteria 1 . Thus for carbapenem-resistant isolates MIC was also determined for chloramphenicol, colistin, fosfomycin, minocycline and tigecycline. Fosfomycin which was previously used mainly as oral treatment for uncomplicated urinary tract infections, currently attracts clinicians' interest worldwide. Particularly, the reported activity against pathogens with advanced resistance suggests that this antibiotic may provide a useful option for the treatment of patients with these difficult to treat infections 12 . In our study 88 per cent CRE were sensitive to fosfomycin.
Colistin and polymyxin B have recently regained significant interest as a consequence of the increasing incidence of infections due to carbapenem-resistant bacteria and are reconsidered as last-resort antibiotics 13 . Results of this study demonstrated that 78 per cent of P. aeruginosa and 85 per cent Acinetobacter spp. were sensitive to colistin. Indian data on colistin resistance from ICMR document 8 reported colistin resistance of 10 per cent in P. aeruginosa and 22 per cent in A. baumannii complex. Another study from north India reported colistin resistance in carbapenem resistance A. baumannii as 16 per cent 14 . The use of polymyxins has been challenged by the emergence of the plasmid-borne mobile colistin resistance gene (mcr-1) 15 . Since MCR-1 is capable of horizontal transfer between different strains of a bacterial species and after its discovery in November 2015 in E. coli (strain SHP45) from a pig in China, it has been found in E. coli, Salmonella enterica, Klebsiella pneumonia, Enterobacter aerogenes and Enterobacter cloacae 15 .
Results of our study show that 70 per cent of Acinetobacter spp. and 50 per cent carbapenem-resistant enterobacteriaceae (CRE) were sensitive to minocycline.
The study results were in concurrence to other Indian and western literature 16, 17 . Tigecycline is a structural analogue of minocycline that was designed to avoid tetracycline resistance mediated by ribosomal protection and drug efflux 18 . It is indicated for the treatment of complicated skin infections, intra-abdominal infections and community-acquired bacterial pneumonia 19 . This study results showed 36 per cent tigecycline resistance in CRE in concurrence with other Indian studies 20, 21 .
In conclusion, carbapenem resistance in the GNB from the community and hospital settings is on rise and should be closely monitored. In the absence of new antibiotics in pipeline and limited therapeutic options, it is important to prudently use antibiotics and strict infection control practices should be followed in the hospital to limit the emergence and spread of multidrug-resistant bacteria. 
